Finorify

TMDX

TransMedics Group

$75.86+0.64%

Price

TMDX daily closing price
Market cap
$2.62 billion
P/E (TTM)
19.65
EV/EBITDA
22.23
Volume
565.0K
Sector
Healthcare

TransMedics Group (TMDX) last closed at $75.86, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for TMDX, covered for search and blurred for visitors.

Performance

  • 1D-3.14%
  • 5D-4.13%
  • 1M-17.79%
  • 3M+1.79%
  • 6M-36.85%
  • 1Y-39.62%
  • 5Y+158.76%

Financials

TMDX revenueQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, TransMedics Group reported revenue of $668.5 million.

The prior window totaled $531.3 million, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $145.9 million.

Free cash flow in the latest window was $79 million.

These amounts are taken from TransMedics Group's SEC filings and are a snapshot as of August 14, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 2.8% (30 of 100). Cash generation: FCF margin 11.8% (24 of 100). Net margin: 7.7% (19 of 100). Liquidity: Current 6.62× (100 of 100).

Cash Flow

TMDX free cash flowQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Margins

TMDX operating margin

Valuation

P/E (TTM)
19.65
P/S (TTM)
3.92
EV/EBITDA
22.23

Insights

Finorify has not written notes for TMDX in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open TMDX in Finorify